79
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Clinicopathological and survival analysis of uterine papillary serous carcinoma: a single institutional review of 106 cases

, , , , &
Pages 4915-4928 | Published online: 25 Oct 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Tao Zhang, Qin Liu, Yingfan Zhu, Songfa Zhang, Qiaohua Peng, Amanda Louise Strickland, Wenxin Zheng & Feng Zhou. (2021) PD-L1 Expression in Endometrial Serous Carcinoma and Its Prognostic Significance. Cancer Management and Research 13, pages 9157-9165.
Read now

Articles from other publishers (18)

Wenxue Zhi, Yang Zhan, Chunyan He & Yulan Jin. (2023) Distinct histological and clinical features associated with pure uterine serous carcinoma: A single institution experience. Annals of Diagnostic Pathology 66, pages 152173.
Crossref
N. V. Kovalenko, A. Yu. Maksimov, E. V. Verenikina & A. A. Demidova. (2023) Differential possibilities of determination of molecular markers in uterine aspirate in endometrial and non-endometrial cancer of uterine body. Medical alphabet:10, pages 25-28.
Crossref
Amrita Datta, Vinotha Thomas, Ajit Sebastian, Rachel George, Anitha Thomas, Thomas Samuel Ram, Sherin Daniel, K. Reka & Abraham Peedicayil. (2023) The clinico pathological features and survival in serous endometrial cancers. Gynecologic Oncology Reports 47, pages 101194.
Crossref
Esra KELES, Serkan AKIŞ, Şefik ÖZYÜREK, Uğur Kemal ÖZTÜRK, Yunus Emre PURUT, Canan KABACA & Murat APİ. (2022) How specific are CA-125 levels in ruling out extra-uterine extension of endometrial serous papillary cancer?CA-125 seviyeleri, Endometrial seröz karsinomun uterus dışı yayılımının dışlanmasında ne kadar spesifiktir?. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi 19:2, pages 1255-1259.
Crossref
Sònia Gatius, Mariona Jove, Cristina Megino-Luque, Manel Albertí-Valls, Andree Yeramian, Nuria Bonifaci, Miquel Piñol, Maria Santacana, Irene Pradas, David Llobet-Navas, Reinald Pamplona, Xavier Matías-Guiu & Núria Eritja. (2022) Metabolomic Analysis Points to Bioactive Lipid Species and Acireductone Dioxygenase 1 (ADI1) as Potential Therapeutic Targets in Poor Prognosis Endometrial Cancer. Cancers 14:12, pages 2842.
Crossref
Hui Xu, Shuang-Shuang Cui, Lin Ran, Yi Liu, Cui Hu, Yu Xu & Yong Tian. (2022) Incidence of omental metastasis in uterine serous carcinoma: a systematic review and meta-analysis. Journal of Gynecology Obstetrics and Human Reproduction 51:6, pages 102395.
Crossref
Kanako Sendo, Manabu Seino, Tsuyoshi Ohta & Satoru Nagase. (2022) Impact of the glutathione synthesis pathway on sulfasalazine-treated endometrial cancer. Oncotarget 13:1, pages 224-236.
Crossref
Antonino Ditto, Umberto Leone Roberti Maggiore, Salvatore Lopez, Fabio Martinelli, Giorgio Bogani, Salvatore Lo Vullo, Claudia Brusadelli, Biagio Paolini, Monika Ducceschi, Mara Mantiero, Valentina Chiappa, Mauro Signorelli, Mariateresa Evangelista, Luigi Mariani & Francesco Raspagliesi. (2022) Uterine serous carcinoma: role of surgery, risk factors and oncologic outcomes. Experience of a tertiary center. European Journal of Surgical Oncology 48:1, pages 268-274.
Crossref
K. Archana Vasuki & H. Jemmy Christy. (2021) Comprehensive Study of Human FBXW7 Deleterious nsSNP’s Functional Inference and Susceptibility to Gynaecological Cancer. Applied Biochemistry and Biotechnology 194:1, pages 407-433.
Crossref
Benjamin B. Albright, Karen A. Monuszko, Samantha J. Kaplan, Brittany A. Davidson, Haley A. Moss, Allan B. Huang, Alexander Melamed, Jason D. Wright, Laura J. Havrilesky & Rebecca A. Previs. (2021) Primary cytoreductive surgery for advanced stage endometrial cancer: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology 225:3, pages 237.e1-237.e24.
Crossref
Constantin A Dasanu, Jaren Lerner, Miguel Michel Ocampo, Andrew S Iskandar, Jaspreet Kaur, Shahat Tuler, Ion Codreanu, Stephanie Farrell & Steven C Plaxe. (2021) Advanced uterine papillary serous cancer: Could there be a role for newer targeted therapeutic approaches or immune checkpoint inhibitors?. Journal of Oncology Pharmacy Practice 27:5, pages 1181-1185.
Crossref
Ying Han & Chongdong Liu. (2021) Clinicopathological characteristics and prognosis of uterine serous carcinoma: A SEER program analysis of 1016 cases. Journal of Obstetrics and Gynaecology Research 47:7, pages 2460-2472.
Crossref
Giorgio Bogani, Isabelle Ray-Coquard, Nicole Concin, Natalie Y.L. Ngoi, Philippe Morice, Takayuki Enomoto, Kazuhiro Takehara, Hannelore Denys, Remi A. Nout, Domenica Lorusso, Michelle M. Vaughan, Marta Bini, Masashi Takano, Diane Provencher, Alice Indini, Satoru Sagae, Pauline Wimberger, Robert Póka, Yakir Segev, Se Ik Kim, Francisco J. Candido dos Reis, Salvatore Lopez, Andrea Mariani, Mario M. LeitaoJrJr, Francesco Raspagliesi, Pieluigi Benedetti Panici, Violante Di Donato, Ludovico Muzii, Nicoletta Colombo, Giovanni Scambia, Sandro Pignata & Bradley J. Monk. (2021) Uterine serous carcinoma. Gynecologic Oncology 162:1, pages 226-234.
Crossref
Caner Cakir, Fatih Kilic, Cigdem Kilic, Nedim Tokgozoglu, Burak Ersak, Sevgi Ayhan, Serra Akar, Dilek Yuksel, Vakkas Korkmaz, Nurettin Boran, Tayfun Toptas, Gunsu Kimyon Comert, Isin Ureyen, Tolga Tasci, Osman Turkmen, Ozlem Moraloglu Tekin, Yaprak Ustun & Taner Turan. (2021) The role of lymphadenectomy in patients with stage III&IV uterine serous carcinoma: Results of multicentric Turkish study. Journal of Gynecology Obstetrics and Human Reproduction 50:5, pages 102063.
Crossref
Hui Chen, Lingjun Li, Ping Qin, Hanzhen Xiong, Ruichao Chen, Minfen Zhang & Qingping Jiang. (2021) A 4-gene signature predicts prognosis of uterine serous carcinoma. BMC Cancer 21:1.
Crossref
Mary Ellen Urick & Daphne W. Bell. (2020) Proteomic profiling of FBXW7 ‐mutant serous endometrial cancer cells reveals upregulation of PADI2, a potential therapeutic target . Cancer Medicine 9:11, pages 3863-3874.
Crossref
Lihua Chen, Xiaona Liu, Mengjiao Li, Shuoer Wang, Hongyu Zhou, Lei Liu & Xi Cheng. (2019) A novel model to predict cancer‐specific survival in patients with early‐stage uterine papillary serous carcinoma (UPSC). Cancer Medicine 9:3, pages 988-998.
Crossref
Ming Chen, Peng Guo, Jifan Tan, Duo Liu & Shuzhong Yao. (2019) The role of omentectomy in the surgical treatment of uterine serous carcinoma. European Journal of Obstetrics & Gynecology and Reproductive Biology: X 4, pages 100084.
Crossref